Han-ying Huang
State Key Laboratory Of Oncology In South China
Guangzhou, 500060, China
Guangzhou, 500060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
A click-compatible BmTyr platform for biotin-free proximity labeling and subcellular proteome profiling in primary T cells.
Journal: Biochemical and biophysical research communications
Published: May 07, 2026
Kill two birds with one stone: Reprogramming tumor microenvironment with growth differentiation factor 11.
Journal: World journal of gastroenterology
Published: October 15, 2025
Ontogeny specification and epigenetic regulation of macrophage plasticity.
Journal: Frontiers in immunology
Published: July 31, 2025
Modeling tumor relapse using proliferation tracing and ablation transgenic mouse.
Journal: NPJ breast cancer
Published: May 31, 2025
Vascular-Associated Mononuclear Phagocytes: First-Line Soldiers Ambushing Metastasis.
Journal: BioEssays : news and reviews in molecular, cellular and developmental biology
Published: November 05, 2024
Alternations in inflammatory macrophage niche drive phenotypic and functional plasticity of Kupffer cells.
Journal: Nature communications
Published: April 17, 2024
Development and validation of a tumor immune cell infiltration-related gene signature for recurrence prediction by weighted gene co-expression network analysis in prostate cancer.
Journal: Frontiers in genetics
Published: October 11, 2022
Predicting Survival of Patients with Nonmetastatic Breast Cancer Based on Fibrinogen-to-Albumin Ratio and Lymphocyte-to-Monocyte Ratio: A Nomogram-Based Assessment.
Journal: Breast care (Basel, Switzerland)
Published: February 28, 2022
Pan-Immune-Inflammation Value: A New Prognostic Index in Operative Breast Cancer.
Journal: Frontiers in oncology
Published: December 06, 2021
A Prognostic Survival Model of Pancreatic Adenocarcinoma Based on Metabolism-Related Gene Expression.
Journal: Frontiers in genetics
Published: December 03, 2021
A Model Combining Skeletal Muscle Mass and a Hematological Biomarker to Predict Survival in Patients With Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy.
Journal: Frontiers in oncology
Published: December 21, 2020
Last Updated: 09/26/2026